Body weight gain, insulin, and leptin in olanzapine-treated patients.
Baptista
T
T
Beaulieu
S
S
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D001835:Body Weight / Q000502:physiology*; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D020738:Leptin / Q000097:blood*; D008297:Male; D024821:Metabolic Syndrome / Q000502:physiology*; D009765:Obesity / Q000139:chemically induced*; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D011618:Psychotic Disorders / Q000188:drug therapy*
D014150:Antipsychotic Agents; D007328:Insulin; D020738:Leptin; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine